By
Drug Target Review2025-02-06T13:17:31
Study reveals how type 2 diabetes accelerates cognitive decline by damaging white matter in the brain. Sam Hashemi at Prenuvo explains how advanced AI and whole-body MRI technology are opening new possibilities for early intervention.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-06-22T13:04:00Z
2026-06-22T07:00:00Z
2026-06-19T08:26:00Z
2026-05-26T09:05:00
Contributor Thomas Clozel M.D., By Drug Target Review
2026-05-25T07:00:00
Contributor Professor Neville Sanjana
2025-05-08T10:38:52
Sponsored by Takara Bio USA
2023-01-10T09:50:16
Sponsored by Sartorius Incucyte® Live-Cell Analysis System
2024-01-24T08:45:41
Sponsored by Leica Microsystems
2025-10-22T14:00:00
Sponsored by Wuxi Biologics
Site powered by Webvision Cloud